Call interference of hysteromyoma in IVF
In vitro fertilization (IVF) is a method of combining eggs and sperm and transplanting them into the mother's uterus for pregnancy. However, for women with uterine fibroids, this process may be subject to certain call interference. Next, we will analyze the pathogenesis of uterine fibroids and its impact on IVF.
Pathogenesis of hysteromyoma
Uterine myoma is a common tumor of female reproductive organs. It grows in the myometrium of the uterus and consists of smooth muscle and connective tissue cells. Its pathogenesis is not completely clear, but it is related to hormone, heredity, immunity, environment and other factors. The growth of uterine fibroids is regulated by estrogen and progesterone, which need manual intervention in the process of IVF and may interfere with uterine fibroids.
First, hormone drugs are used during IVF to promote the growth of follicles and increase the number of eggs. These hormones will increase the estrogen level in the body, which may stimulate the growth of uterine fibroids. Secondly, the level of progesterone will rise significantly during pregnancy, which will also affect the growth of uterine fibroids. In conclusion, hormone intervention during IVF may stimulate the growth of uterine fibroids.
Impact on IVF
Uterine fibroids may interfere with the implantation of fertilized eggs and embryo implantation during IVF. The presence of uterine fibroids will lead to the morphological abnormalities and deformation of the uterine cavity, reducing the chances of embryo implantation. Hysteromyoma may also change the blood supply of the endometrium, thus affecting the growth and development of the embryo.
In addition, uterine fibroids may also cause uterine contraction, increasing the risk of embryo abortion. In the process of IVF, the implantation of embryos requires a stable state of endometrium, and the contraction of uterine fibroids may affect the safe implantation of embryos.
Influence on the success rate of IVF
The presence of uterine fibroids may reduce the success rate of IVF. One study found that the success rate of IVF was lower in patients with uterine fibroids larger than 5 cm in diameter. This may be related to the influence of uterine fibroids on the morphology and function of the uterus.
In addition, uterine fibroids may increase the risk of pregnancy complications. If uterine fibroids cause poor uterine dilatation, it may increase the risk of premature delivery and placental abruption. These complications will not only cause risks to the mother, but also adversely affect the development of the embryo.
Summary
Uterine fibroids may have a negative impact on the success rate during IVF. Its pathogenesis is related to hormone regulation. Hormone intervention during IVF may stimulate the growth of uterine fibroids. Hysteromyoma may interfere with the implantation and implantation of IVF by changing the shape and function of the uterus, affecting the blood supply of the endometrium and increasing uterine contraction. In addition, uterine fibroids may also reduce the success rate of IVF and increase the risk of pregnancy complications. Therefore, before IVF treatment, women with uterine fibroids should be comprehensively evaluated and treated.
